Poniard Pharmaceuticals Announces Treatment of First Patient in ...
PipelineReview.com (press release), Spain -Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced treatment of the first patient in a Phase 1 ...